SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B2 - Prospectus [Rule 424(b)(2)]:
SEC Accession No. 0001193125-12-253557
Filing Date
2012-05-30
Accepted
2012-05-30 16:39:36
Documents
3

Document Format Files

Seq Description Document Type Size
1 FILED PURSUANT TO RULE 424(B)(2) d359650d424b2.htm 424B2 684717
2 GRAPHIC g359650g38q16.jpg GRAPHIC 13746
3 GRAPHIC g359650g57l23.jpg GRAPHIC 12385
  Complete submission text file 0001193125-12-253557.txt   721989
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062827100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 424B2 | Act: 33 | File No.: 333-161442 | Film No.: 12878135
SIC: 2834 Pharmaceutical Preparations